Document Detail


Phlegmasia cerulea dolens: the role of non-operative therapy.
MedLine Citation:
PMID:  8076089     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thrombectomy and thrombolysis are often advocated in the treatment of phlegmasia cerulea dolens, but frequently result in incomplete clot removal, recurrence of thrombosis, local and systemic hemorrhagic complications and chronic venous stasis; this state is associated with a rate of major amputation and death of up to 50%. Non-operative therapy includes elevation, hydration and heparinization and excludes all methods aimed at surgical removal or chemical lysis of the thrombus. In 1982 it was decided to use non-operative therapy as the first line of treatment for phlegmasia cerulea dolens. In the last 9 years seven extremities in six patients with this condition have been treated. One patient had advanced gangrene on presentation and one underwent emergency thrombectomy. Five extremities (in five patients) were treated with non-operative therapy. Ischemia was rapidly corrected in all five patients. Edema resolved completely after 3-4 days in four patients. There were no complications attributable to the therapy. Two of six (33%) patients died from terminal disease. Non-operative therapy appears to be effective in preventing limb loss and avoiding the risks of thrombectomy and thrombolysis in critically ill patients.
Authors:
K R Patel; C N Paidas
Related Documents :
6689089 - Management of an infected aneurysm of the groin secondary to drug abuse.
11869699 - Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma.
6697129 - Prediction of amputation wound healing: the role of transcutaneous po2 assessment.
2512979 - Acute peripheral arterial ischemia: a prospective evaluation of differential management...
20300599 - Rituximab efficacy during a refractory polyarteritis nodosa flare.
4094969 - An improved modality in lower extremity amputee rehabilitation.
22959319 - Clinical outcome score predicts the need for neurodevelopmental intervention after infa...
21288279 - Impact of patent foramen ovale on left atrial linear lesions in the context of atrial f...
24526709 - The persistent and broadly modulating effect of inhibitory rtms in nonfluent aphasic pa...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cardiovascular surgery (London, England)     Volume:  1     ISSN:  0967-2109     ISO Abbreviation:  Cardiovasc Surg     Publication Date:  1993 Oct 
Date Detail:
Created Date:  1994-10-06     Completed Date:  1994-10-06     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9308765     Medline TA:  Cardiovasc Surg     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  518-23     Citation Subset:  IM    
Affiliation:
Department of Surgery (12A3), Metropolitan Hospital Center, New York 10029.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Amputation
Combined Modality Therapy
Female
Follow-Up Studies
Foot / blood supply
Gangrene
Heparin / administration & dosage
Humans
Ischemia / etiology,  mortality,  therapy*
Leg / blood supply*
Male
Middle Aged
Survival Rate
Thrombophlebitis / etiology,  mortality,  therapy*
Vena Cava Filters
Chemical
Reg. No./Substance:
9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ultrasonic characterization of the saphenous vein.
Next Document:  Pathogenesis of lipodermatosclerosis of venous disease: the lesson learned from eosinophilic fasciit...